BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 9844059)

  • 1. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
    Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
    Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial.
    Rostoker G; Desvaux-Belghiti D; Pilatte Y; Petit-Phar M; Philippon C; Deforges L; Terzidis H; Intrator L; André C; Adnot S
    Nephron; 1995; 69(3):327-34. PubMed ID: 7753269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schönlein nephritis.
    Rauta V; Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
    Nephrol Dial Transplant; 2003 Sep; 18(9):1785-91. PubMed ID: 12937225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
    Wu TH; Wu SC; Huang TP; Yu CL; Tsai CY
    Nephron; 1996; 74(1):79-88. PubMed ID: 8883024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
    Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of cytokine expression in patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Fadden K; Rifai A
    J Clin Immunol; 1997 Sep; 17(5):396-403. PubMed ID: 9327339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes in acute adult-onset Henoch-Schonlein nephritis.
    Hilhorst M; van Paassen P; van Breda Vriesman P; Cohen Tervaert JW
    Nephrol Dial Transplant; 2011 Dec; 26(12):3960-7. PubMed ID: 21441402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
    Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent levels of select immunological mediators in sera of healthy children.
    Sack U; Burkhardt U; Borte M; Schädlich H; Berg K; Emmrich F
    Clin Diagn Lab Immunol; 1998 Jan; 5(1):28-32. PubMed ID: 9455875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
    Jónasdóttir O; Petersen J; Bendtzen K
    APMIS; 2001 Nov; 109(11):781-6. PubMed ID: 11900058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
    Li MM; Liu N; Zhagn M; Xue HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble receptors and cytokine antagonists in human milk.
    Buescher ES; Malinowska I
    Pediatr Res; 1996 Dec; 40(6):839-44. PubMed ID: 8947960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.